Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Aug 14, 2023. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q2 2023. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 28.6B USD
- Positions
- 1,531
- Share of the ten largest
- 12.7%
The ten largest positions Q2 2023
- Nvidia 2.4%▲ +67.5%
- Microsoft 2.2%▲ +305.9%
- Amazon 1.4%▼ −24.7%
- Adobe Inc. 1.3%▲ +51.2%
- T-Mobile US 1.2%▲ +48.2%
- AutoZone 0.9%▲ +69.8%
- Meta Platforms 0.8%▼ −66.1%
- Zimmer Biomet 0.8%▲ +119.6%
- Dell Technologies 0.8%▲ +22.3%
- Take-Two Interactive 0.8%▼ −19.0%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q2 2023
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| AMZN Amazon | 1.4% | 3,037,918 | 396.0M USD | −24.7% reduced | Q1 2017 26 quarters |
| META Meta Platforms | 0.8% | 837,427 | 240.3M USD | −66.1% reduced | Q2 2020 13 quarters |
| TTWO Take-Two Interactive | 0.8% | 1,471,842 | 216.6M USD | −19.0% reduced | Q3 2021 8 quarters |
| WMT Walmart | 0.6% | 1,139,778 | 179.2M USD | −59.5% reduced | Q1 2023 2 quarters |
| BIIB Biogen | 0.6% | 625,641 | 178.2M USD | −10.0% reduced | Q3 2020 12 quarters |
| CSX CSX Corporation | 0.5% | 4,540,003 | 154.8M USD | −18.8% reduced | Q3 2020 12 quarters |
| RVTY Revvity | 0.5% | 1,190,011 | 141.4M USD | −11.3% reduced | Q4 2022 3 quarters |
| Stoneco Ltd | 0.5% | 10,886,400 | 138.7M USD | −10.9% reduced | Q4 2021 7 quarters |
| T AT&T | 0.5% | 8,521,800 | 135.9M USD | −11.3% reduced | Q1 2023 2 quarters |
| NSC Norfolk Southern | 0.4% | 556,233 | 126.1M USD | −23.5% reduced | Q1 2023 2 quarters |
| FIS Fidelity National Information Services | 0.4% | 2,305,869 | 126.1M USD | −20.4% reduced | Q1 2019 18 quarters |
| MCD McDonald's | 0.4% | 405,923 | 121.1M USD | −58.0% reduced | Q4 2022 3 quarters |
| ADI Analog Devices | 0.4% | 591,545 | 115.2M USD | −57.6% reduced | Q2 2020 13 quarters |
| LULU Lululemon Athletica | 0.4% | 298,358 | 112.9M USD | −58.3% reduced | Q2 2022 5 quarters |
| Exact Sciences Corp | 0.4% | 1,190,936 | 111.8M USD | −19.5% reduced | Q3 2022 4 quarters |
| Shell PLC | 0.4% | 1,661,650 | 100.3M USD | −50.1% reduced | Q1 2022 6 quarters |
| Novartis AG | 0.3% | 906,286 | 91.5M USD | −50.0% reduced | Q2 2022 5 quarters |
| ANET Arista Networks | 0.3% | 548,607 | 88.9M USD | −74.5% reduced | Q1 2021 10 quarters |
| CPRT Copart | 0.3% | 972,315 | 88.7M USD | −28.4% reduced | Q2 2022 5 quarters |
| Pacific Biosciences Calif In | 0.3% | 6,661,633 | 88.6M USD | −8.6% reduced | Q3 2022 4 quarters |
| RAPID7 Inc | 0.3% | 1,937,015 | 87.7M USD | −16.5% reduced | Q1 2023 2 quarters |
| VRTX Vertex Pharmaceuticals | 0.3% | 246,439 | 86.7M USD | −4.7% reduced | Q3 2022 4 quarters |
| TRGP Targa Resources | 0.3% | 1,133,579 | 86.3M USD | −33.5% reduced | Q3 2019 16 quarters |
| ABBV AbbVie | 0.3% | 620,999 | 83.7M USD | −39.6% reduced | Q1 2023 2 quarters |
| FANG Diamondback Energy | 0.3% | 627,858 | 82.5M USD | −15.4% reduced | Q3 2022 4 quarters |
| BABA Alibaba Group (ADR) | 0.3% | 961,363 | 80.1M USD | −63.6% reduced | Q4 2021 7 quarters |
| Burlington Stores Inc | 0.3% | 503,071 | 79.2M USD | −5.2% reduced | Q1 2023 2 quarters |
| EMR Emerson Electric | 0.3% | 870,824 | 78.7M USD | −42.4% reduced | Q1 2023 2 quarters |
| Surgery Partners Inc | 0.3% | 1,621,604 | 73.0M USD | −11.5% reduced | Q3 2021 8 quarters |
| PM Philip Morris International | 0.3% | 747,292 | 73.0M USD | −3.3% reduced | Q4 2022 3 quarters |
| BAX Baxter International | 0.2% | 1,554,804 | 70.8M USD | −57.1% reduced | Q1 2023 2 quarters |
| Chewy Inc | 0.2% | 1,753,087 | 69.2M USD | −11.2% reduced | Q1 2023 2 quarters |
| ETR Entergy | 0.2% | 682,000 | 66.4M USD | −51.1% reduced | Q1 2022 6 quarters |
| V Visa Inc. | 0.2% | 278,355 | 66.1M USD | −54.0% reduced | Q3 2020 12 quarters |
| CMG Chipotle Mexican Grill | 0.2% | 30,698 | 65.7M USD | −28.8% reduced | Q4 2022 3 quarters |
| TECH Bio-Techne | 0.2% | 788,697 | 64.4M USD | −18.4% reduced | Q4 2022 3 quarters |
| MRSH Marsh McLennan | 0.2% | 336,680 | 63.3M USD | −42.9% reduced | Q2 2021 9 quarters |
| Exelixis Inc | 0.2% | 3,310,580 | 63.3M USD | −2.1% reduced | Q1 2020 14 quarters |
| AES AES Corporation | 0.2% | 3,041,800 | 63.1M USD | −1.5% reduced | Q4 2022 3 quarters |
| EXC Exelon | 0.2% | 1,537,440 | 62.6M USD | −27.9% reduced | Q3 2022 4 quarters |
| INTC Intel | 0.2% | 1,789,997 | 59.9M USD | −82.8% reduced | Q1 2023 2 quarters |
| WSM Williams-Sonoma, Inc. | 0.2% | 461,675 | 57.8M USD | −33.8% reduced | Q1 2023 2 quarters |
| Imperial Oil Ltd | 0.2% | 1,113,936 | 57.0M USD | −18.8% reduced | Q4 2022 3 quarters |
| Gallagher Arthur J & Co | 0.2% | 258,289 | 56.7M USD | −32.7% reduced | Q2 2021 9 quarters |
| AVGO Broadcom | 0.2% | 64,978 | 56.4M USD | −90.8% reduced | Q3 2021 8 quarters |
| Southwestern Energy Co | 0.2% | 9,271,467 | 55.7M USD | −8.1% reduced | Q3 2022 4 quarters |
| IOVA Iovance Biotherapeutics | 0.2% | 7,786,985 | 54.8M USD | −11.5% reduced | Q1 2023 2 quarters |
| Azek Co Inc | 0.2% | 1,795,517 | 54.4M USD | −8.1% reduced | Q4 2022 3 quarters |
| Murphy Oil Corp | 0.2% | 1,403,470 | 53.8M USD | −12.7% reduced | Q4 2022 3 quarters |
| ETN Eaton Corporation | 0.2% | 263,300 | 52.9M USD | −23.6% reduced | Q1 2023 2 quarters |
| OXY Occidental Petroleum | 0.2% | 885,282 | 52.1M USD | −50.8% reduced | Q3 2022 4 quarters |
| HLT Hilton Worldwide | 0.2% | 357,317 | 52.0M USD | −32.0% reduced | Q4 2021 7 quarters |
| UHS Universal Health Services | 0.2% | 310,969 | 49.1M USD | −53.6% reduced | Q4 2022 3 quarters |
| LNT Alliant Energy | 0.2% | 932,000 | 48.9M USD | −16.9% reduced | Q2 2022 5 quarters |
| VST Vistra Corp. | 0.2% | 1,826,122 | 47.9M USD | −25.5% reduced | Q1 2021 10 quarters |
| RIVN Rivian Automotive | 0.2% | 2,812,092 | 46.8M USD | −44.1% reduced | Q4 2022 3 quarters |
| Western Alliance Bancorp | 0.2% | 1,207,306 | 44.0M USD | −13.6% reduced | Q1 2021 10 quarters |
| Inari Med Inc | 0.1% | 681,100 | 39.6M USD | −74.7% reduced | Q1 2023 2 quarters |
| Aercap Holdings NV | 0.1% | 621,500 | 39.5M USD | −45.7% reduced | Q1 2022 6 quarters |
| WRB W. R. Berkley Corporation | 0.1% | 642,986 | 38.3M USD | −45.9% reduced | Q2 2020 13 quarters |
| BA Boeing | 0.1% | 181,313 | 38.3M USD | −58.6% reduced | Q1 2023 2 quarters |
| Healthequity Inc | 0.1% | 604,897 | 38.2M USD | −11.3% reduced | Q4 2021 7 quarters |
| HWM Howmet Aerospace | 0.1% | 766,652 | 38.0M USD | −59.2% reduced | Q4 2020 11 quarters |
| DHR Danaher Corporation | 0.1% | 151,356 | 36.3M USD | −78.0% reduced | Q1 2023 2 quarters |
| Ally Finl Inc | 0.1% | 1,297,999 | 35.1M USD | −30.5% reduced | Q1 2023 2 quarters |
| CHTR Charter Communications | 0.1% | 94,742 | 34.8M USD | −54.9% reduced | Q2 2022 5 quarters |
| Axsome Therapeutics Inc | 0.1% | 468,003 | 33.6M USD | −60.0% reduced | Q2 2022 5 quarters |
| Takeda Pharmaceutical Co Ltd | 0.1% | 2,125,500 | 33.4M USD | −15.9% reduced | Q4 2022 3 quarters |
| Comerica Inc | 0.1% | 775,747 | 32.9M USD | −43.4% reduced | Q4 2021 7 quarters |
| American Finl Group Inc Ohio | 0.1% | 262,283 | 31.1M USD | −25.8% reduced | Q4 2018 19 quarters |
| AMP Ameriprise Financial | 0.1% | 93,300 | 31.0M USD | −16.9% reduced | Q3 2021 8 quarters |
| CNC Centene Corporation | 0.1% | 458,457 | 30.9M USD | −63.3% reduced | Q4 2022 3 quarters |
| KO Coca-Cola Company (The) | 0.1% | 505,392 | 30.4M USD | −13.8% reduced | Q4 2022 3 quarters |
| CME CME Group | 0.1% | 161,802 | 30.0M USD | −21.8% reduced | Q2 2014 or earlier 37 quarters |
| JCI Johnson Controls | 0.1% | 438,472 | 29.9M USD | −37.9% reduced | Q1 2023 2 quarters |
| Anaptysbio Inc | 0.1% | 1,459,909 | 29.7M USD | −13.2% reduced | Q4 2021 7 quarters |
| COO Cooper Companies (The) | 0.1% | 75,898 | 29.1M USD | −16.5% reduced | Q1 2022 6 quarters |
| LIN Linde plc | 0.1% | 75,952 | 28.9M USD | −50.5% reduced | Q1 2023 2 quarters |
| Waste Connections Inc | < 0.1% | 196,486 | 28.1M USD | −20.9% reduced | Q3 2022 4 quarters |
| Biohaven Ltd | < 0.1% | 1,170,798 | 28.0M USD | −57.0% reduced | Q3 2022 4 quarters |
| NFLX Netflix | < 0.1% | 63,392 | 27.9M USD | −76.2% reduced | Q4 2022 3 quarters |
| Bio Rad Labs Inc | < 0.1% | 73,459 | 27.8M USD | −58.0% reduced | Q2 2021 9 quarters |
| OSCR Oscar Health | < 0.1% | 3,414,100 | 27.5M USD | −12.1% reduced | Q4 2022 3 quarters |
| Abercrombie & Fitch Co | < 0.1% | 730,279 | 27.5M USD | −51.4% reduced | Q2 2022 5 quarters |
| Option Care Health Inc | < 0.1% | 835,256 | 27.1M USD | −80.4% reduced | Q3 2022 4 quarters |
| Ventyx Biosciences Inc | < 0.1% | 799,000 | 26.2M USD | −25.3% reduced | Q4 2022 3 quarters |
| KKR KKR & Co. | < 0.1% | 441,900 | 24.7M USD | −36.0% reduced | Q3 2021 8 quarters |
| EQIX Equinix | < 0.1% | 30,540 | 23.9M USD | −61.6% reduced | Q1 2023 2 quarters |
| EQT EQT Corporation | < 0.1% | 579,703 | 23.8M USD | −78.1% reduced | Q1 2023 2 quarters |
| PHM PulteGroup | < 0.1% | 303,931 | 23.6M USD | −36.4% reduced | Q4 2022 3 quarters |
| Skechers U S A Inc | < 0.1% | 438,299 | 23.1M USD | −72.3% reduced | Q1 2023 2 quarters |
| Middleby Corp | < 0.1% | 152,593 | 22.6M USD | −65.5% reduced | Q3 2022 4 quarters |
| CCL Carnival Corporation | < 0.1% | 1,189,217 | 22.4M USD | −73.2% reduced | Q1 2023 2 quarters |
| Enovix Corporation | < 0.1% | 1,204,477 | 21.7M USD | −17.3% reduced | Q3 2022 4 quarters |
| Post HLDGS Inc | < 0.1% | 248,308 | 21.5M USD | −26.7% reduced | Q4 2020 11 quarters |
| JBHT J.B. Hunt | < 0.1% | 117,932 | 21.3M USD | −59.1% reduced | Q4 2022 3 quarters |
| NXPI NXP Semiconductors | < 0.1% | 100,145 | 20.5M USD | −14.1% reduced | Q1 2023 2 quarters |
| Copa Holdings SA | < 0.1% | 184,284 | 20.4M USD | −66.6% reduced | Q4 2022 3 quarters |
| Omnicell Com | < 0.1% | 276,228 | 20.3M USD | −55.4% reduced | Q1 2023 2 quarters |
| BIDU Baidu (ADR) | < 0.1% | 148,100 | 20.3M USD | −72.0% reduced | Q4 2022 3 quarters |
| Voya Financial Inc | < 0.1% | 280,178 | 20.1M USD | −67.3% reduced | Q1 2023 2 quarters |
| Oge Energy Corp | < 0.1% | 551,512 | 19.8M USD | −9.2% reduced | Q3 2020 12 quarters |
| Ultragenyx Pharmaceutical In | < 0.1% | 424,874 | 19.6M USD | −69.4% reduced | Q4 2020 11 quarters |
| Agree Rlty Corp | < 0.1% | 297,094 | 19.4M USD | −39.0% reduced | Q4 2021 7 quarters |
| Ferguson PLC New | < 0.1% | 120,328 | 18.9M USD | −54.8% reduced | Q2 2022 5 quarters |
| Vericel Corp | < 0.1% | 500,886 | 18.8M USD | −46.4% reduced | Q1 2023 2 quarters |
| RUN Sunrun | < 0.1% | 1,028,888 | 18.4M USD | −49.5% reduced | Q4 2020 11 quarters |
| Alight Inc | < 0.1% | 1,917,439 | 17.7M USD | −25.3% reduced | Q3 2021 8 quarters |
| Point Biopharma Global Inc | < 0.1% | 1,929,167 | 17.5M USD | −38.1% reduced | Q1 2022 6 quarters |
| BNY BNY Mellon | < 0.1% | 388,196 | 17.3M USD | −49.9% reduced | Q4 2022 3 quarters |
| CF CF Industries | < 0.1% | 245,954 | 17.1M USD | −32.8% reduced | Q1 2023 2 quarters |
| Visteon Corp | < 0.1% | 115,999 | 16.7M USD | −30.6% reduced | Q1 2023 2 quarters |
| Warner Music Group Corp | < 0.1% | 638,306 | 16.7M USD | −60.4% reduced | Q3 2021 8 quarters |
| HON Honeywell Technologies | < 0.1% | 80,103 | 16.6M USD | −86.7% reduced | Q1 2023 2 quarters |
| SIRI Sirius XM | < 0.1% | 3,656,495 | 16.6M USD | −16.4% reduced | Q1 2023 2 quarters |
| Universal Display Corp | < 0.1% | 114,591 | 16.5M USD | −48.5% reduced | Q1 2023 2 quarters |
| Privia Health Group Inc | < 0.1% | 631,210 | 16.5M USD | −80.8% reduced | Q4 2022 3 quarters |
| Royalty Pharma PLC | < 0.1% | 530,200 | 16.3M USD | −14.3% reduced | Q1 2023 2 quarters |
| Ati Inc | < 0.1% | 364,559 | 16.1M USD | −41.4% reduced | Q3 2022 4 quarters |
| IFF International Flavors & Fragrances | < 0.1% | 202,428 | 16.1M USD | −30.1% reduced | Q1 2023 2 quarters |
| Darling Ingredients Inc | < 0.1% | 248,623 | 15.9M USD | −71.3% reduced | Q3 2022 4 quarters |
| Landstar Sys Inc | < 0.1% | 80,041 | 15.4M USD | −5.3% reduced | Q3 2022 4 quarters |
| National Vision HLDGS Inc | < 0.1% | 626,963 | 15.2M USD | −3.0% reduced | Q1 2023 2 quarters |
| Booz Allen Hamilton Hldg Cor | < 0.1% | 136,332 | 15.2M USD | −65.9% reduced | Q2 2021 9 quarters |
| Prothena Corp PLC | < 0.1% | 218,802 | 14.9M USD | −34.7% reduced | Q2 2021 9 quarters |
| Rpm Intl Inc | < 0.1% | 166,397 | 14.9M USD | −54.4% reduced | Q1 2022 6 quarters |
| Gritstone Bio Inc | < 0.1% | 7,573,680 | 14.8M USD | −1.4% reduced | Q4 2022 3 quarters |
| Piedmont Lithium Inc | < 0.1% | 249,957 | 14.4M USD | −9.1% reduced | Q1 2023 2 quarters |
| Marinus Pharmaceuticals Inc | < 0.1% | 1,325,181 | 14.4M USD | −58.0% reduced | Q4 2022 3 quarters |
| Axis Cap HLDGS Ltd | < 0.1% | 267,345 | 14.4M USD | −3.3% reduced | Q1 2023 2 quarters |
| Itt Inc | < 0.1% | 151,300 | 14.1M USD | −7.9% reduced | Q4 2022 3 quarters |
| Ishares TR | < 0.1% | 518,417 | 14.1M USD | −10.6% reduced | Q1 2022 6 quarters |
| IDXX Idexx Laboratories | < 0.1% | 28,030 | 14.1M USD | −80.9% reduced | Q3 2022 4 quarters |
| RCL Royal Caribbean Group | < 0.1% | 135,331 | 14.0M USD | −85.8% reduced | Q1 2021 10 quarters |
| Halozyme Therapeutics Inc | < 0.1% | 379,560 | 13.7M USD | −1.0% reduced | Q3 2022 4 quarters |
| Outfront Media Inc | < 0.1% | 823,700 | 12.9M USD | −53.7% reduced | Q1 2023 2 quarters |
| Vir Biotechnology Inc | < 0.1% | 511,600 | 12.5M USD | −69.6% reduced | Q1 2023 2 quarters |
| Bicycle Therapeutics PLC | < 0.1% | 478,000 | 12.2M USD | −40.4% reduced | Q4 2019 15 quarters |
| VICI Vici Properties | < 0.1% | 375,159 | 11.8M USD | −49.9% reduced | Q1 2022 6 quarters |
| Bunge Limited | < 0.1% | 124,275 | 11.7M USD | −68.5% reduced | Q2 2014 or earlier 37 quarters |
| EOSE Eos Energy Enterprises | < 0.1% | 2,626,630 | 11.4M USD | −41.5% reduced | Q3 2022 4 quarters |
| Sabra Health Care REIT Inc | < 0.1% | 958,354 | 11.3M USD | −51.5% reduced | Q1 2022 6 quarters |
| DVA DaVita | < 0.1% | 106,014 | 10.7M USD | −52.0% reduced | Q3 2022 4 quarters |
| Sterling Infrastructure Inc | < 0.1% | 188,615 | 10.5M USD | −12.5% reduced | Q3 2022 4 quarters |
| Acv Auctions Inc | < 0.1% | 590,931 | 10.2M USD | −26.5% reduced | Q3 2021 8 quarters |
| GS Goldman Sachs | < 0.1% | 31,306 | 10.1M USD | −15.1% reduced | Q2 2022 5 quarters |
| PTC PTC Inc. | < 0.1% | 70,500 | 10.0M USD | −80.7% reduced | Q3 2022 4 quarters |
| Karuna Therapeutics Inc | < 0.1% | 45,940 | 10.0M USD | −91.8% reduced | Q3 2022 4 quarters |
| Vaxcyte Inc | < 0.1% | 198,396 | 9.9M USD | −60.4% reduced | Q3 2022 4 quarters |
| Vermilion Energy Inc | < 0.1% | 779,500 | 9.7M USD | −45.6% reduced | Q1 2022 6 quarters |
| Harley Davidson Inc | < 0.1% | 275,952 | 9.7M USD | −46.2% reduced | Q1 2023 2 quarters |
| Wayfair Inc | < 0.1% | 146,089 | 9.5M USD | −89.2% reduced | Q3 2022 4 quarters |
| Nextera Energy Partners LP | < 0.1% | 161,175 | 9.5M USD | −65.9% reduced | Q4 2021 7 quarters |
| Apple Hospitality REIT Inc | < 0.1% | 606,285 | 9.2M USD | −26.6% reduced | Q2 2022 5 quarters |
| New Oriental Ed & Technology | < 0.1% | 226,800 | 9.0M USD | −62.1% reduced | Q4 2022 3 quarters |
| SPDR S&P 500 ETF TR | < 0.1% | 20,000 | 8.9M USD | −1.0% reduced | Q1 2022 6 quarters |
| Cboe Global Mkts Inc | < 0.1% | 63,188 | 8.7M USD | −22.9% reduced | Q2 2022 5 quarters |
| Cirrus Logic Inc | < 0.1% | 106,700 | 8.6M USD | −5.3% reduced | Q1 2023 2 quarters |
| RSG Republic Services | < 0.1% | 55,440 | 8.5M USD | −53.2% reduced | Q2 2022 5 quarters |
| Skyward Specialty Ins Group | < 0.1% | 333,271 | 8.5M USD | −8.5% reduced | Q1 2023 2 quarters |
| Equitable HLDGS Inc | < 0.1% | 300,200 | 8.2M USD | −36.3% reduced | Q1 2020 14 quarters |
| Himax Technologies Inc | < 0.1% | 1,197,276 | 8.1M USD | −14.7% reduced | Q4 2022 3 quarters |
| FCX Freeport-McMoRan | < 0.1% | 200,305 | 8.0M USD | −31.0% reduced | Q3 2021 8 quarters |
| Sunstone Hotel Invs Inc New | < 0.1% | 788,838 | 8.0M USD | −30.6% reduced | Q1 2023 2 quarters |
| Orthopediatrics Corp | < 0.1% | 164,111 | 7.2M USD | −5.3% reduced | Q1 2023 2 quarters |
| MELI MercadoLibre | < 0.1% | 6,047 | 7.2M USD | −79.6% reduced | Q3 2022 4 quarters |
| Quanterix Corp | < 0.1% | 301,541 | 6.8M USD | −13.0% reduced | Q3 2022 4 quarters |
| Genmab A/S | < 0.1% | 177,500 | 6.7M USD | −31.9% reduced | Q1 2023 2 quarters |
| Wolverine World Wide Inc | < 0.1% | 458,800 | 6.7M USD | −5.0% reduced | Q1 2023 2 quarters |
| Cousins Pptys Inc | < 0.1% | 294,363 | 6.7M USD | −72.5% reduced | Q1 2023 2 quarters |
| Macom Tech Solutions HLDGS I | < 0.1% | 101,800 | 6.7M USD | −50.4% reduced | Q1 2023 2 quarters |
| Palomar HLDGS Inc | < 0.1% | 114,470 | 6.6M USD | −32.9% reduced | Q4 2022 3 quarters |
| Nordstrom Inc | < 0.1% | 322,541 | 6.6M USD | −82.4% reduced | Q1 2023 2 quarters |
| Optimizerx Corp | < 0.1% | 461,716 | 6.6M USD | −3.0% reduced | Q1 2023 2 quarters |
| Celanese Corp Del | < 0.1% | 56,676 | 6.6M USD | −71.6% reduced | Q4 2022 3 quarters |
| Noble Corp PLC | < 0.1% | 156,838 | 6.5M USD | −34.0% reduced | Q4 2022 3 quarters |
| Fulcrum Therapeutics Inc | < 0.1% | 1,899,968 | 6.3M USD | −28.1% reduced | Q1 2023 2 quarters |
| Denison Mines Corp | < 0.1% | 5,000,000 | 6.3M USD | −19.6% reduced | Q1 2023 2 quarters |
| Envista Holdings Corporation | < 0.1% | 184,039 | 6.2M USD | −82.8% reduced | Q3 2022 4 quarters |
| Longboard Pharmaceuticals In | < 0.1% | 825,000 | 6.1M USD | −34.0% reduced | Q1 2023 2 quarters |
| MO Altria | < 0.1% | 132,974 | 6.0M USD | −85.0% reduced | Q1 2023 2 quarters |
| American Homes 4 Rent | < 0.1% | 163,008 | 5.8M USD | −28.4% reduced | Q1 2023 2 quarters |
| Shockwave Med Inc | < 0.1% | 20,108 | 5.7M USD | −92.5% reduced | Q4 2022 3 quarters |
| Xenon Pharmaceuticals Inc | < 0.1% | 148,208 | 5.7M USD | −70.6% reduced | Q1 2015 34 quarters |
| Transalta Corp | < 0.1% | 602,272 | 5.6M USD | −53.0% reduced | Q3 2020 12 quarters |
| Reinsurance Grp Of America I | < 0.1% | 40,402 | 5.6M USD | −20.2% reduced | Q1 2023 2 quarters |
| Synaptics Inc | < 0.1% | 64,724 | 5.5M USD | −79.0% reduced | Q4 2022 3 quarters |
| Caesars Entertainment Inc Ne | < 0.1% | 108,311 | 5.5M USD | −75.6% reduced | Q4 2022 3 quarters |
| Syneos Health Inc | < 0.1% | 130,850 | 5.5M USD | −81.7% reduced | Q1 2023 2 quarters |
| PH Parker Hannifin | < 0.1% | 13,902 | 5.4M USD | −89.9% reduced | Q1 2023 2 quarters |
| Embecta Corp | < 0.1% | 249,020 | 5.4M USD | −44.5% reduced | Q1 2023 2 quarters |
| PNW Pinnacle West Capital | < 0.1% | 65,800 | 5.4M USD | −63.6% reduced | Q1 2023 2 quarters |
| Navitas Semiconductor Corp | < 0.1% | 502,998 | 5.3M USD | −43.6% reduced | Q1 2023 2 quarters |
| Aurinia Pharmaceuticals Inc | < 0.1% | 544,720 | 5.3M USD | −71.9% reduced | Q4 2022 3 quarters |
| Angi Inc | < 0.1% | 1,504,814 | 5.0M USD | 0.0% reduced | Q2 2020 13 quarters |
| Viking Therapeutics Inc | < 0.1% | 303,957 | 4.9M USD | −72.2% reduced | Q4 2022 3 quarters |
| Excelerate Energy Inc | < 0.1% | 238,489 | 4.8M USD | −6.7% reduced | Q1 2023 2 quarters |
| Dyne Therapeutics Inc | < 0.1% | 428,529 | 4.8M USD | −53.5% reduced | Q1 2021 10 quarters |
| Diamond Offshore Drilling In | < 0.1% | 333,547 | 4.7M USD | −29.3% reduced | Q1 2023 2 quarters |
| Arch Resources Inc | < 0.1% | 40,500 | 4.6M USD | −63.8% reduced | Q2 2022 5 quarters |
| Abeona Therapeutics Inc | < 0.1% | 1,131,423 | 4.6M USD | −1.7% reduced | Q4 2022 3 quarters |
| Urban Edge Pptys | < 0.1% | 283,515 | 4.4M USD | −41.2% reduced | Q1 2023 2 quarters |
| Smucker J M Co | < 0.1% | 29,351 | 4.3M USD | −74.0% reduced | Q3 2022 4 quarters |
| Hawaiian Elec Industries | < 0.1% | 117,400 | 4.2M USD | −40.2% reduced | Q1 2022 6 quarters |
| Pbf Energy Inc | < 0.1% | 103,143 | 4.2M USD | −84.5% reduced | Q1 2022 6 quarters |
| Aehr Test Sys | < 0.1% | 102,208 | 4.2M USD | −65.6% reduced | Q3 2022 4 quarters |
| PDD PDD Holdings | < 0.1% | 59,140 | 4.1M USD | −73.4% reduced | Q2 2022 5 quarters |
| Consol Energy Inc New | < 0.1% | 59,598 | 4.0M USD | −30.6% reduced | Q1 2023 2 quarters |
| Marqeta Inc | < 0.1% | 828,000 | 4.0M USD | −45.3% reduced | Q4 2021 7 quarters |
| Under Armour Inc | < 0.1% | 548,778 | 4.0M USD | −26.3% reduced | Q4 2022 3 quarters |
| Chinook Therapeutics Inc | < 0.1% | 102,399 | 3.9M USD | −86.0% reduced | Q4 2020 11 quarters |
| ELV Elevance Health | < 0.1% | 8,747 | 3.9M USD | −97.0% reduced | Q4 2022 3 quarters |
| Six Flags Entmt Corp New | < 0.1% | 148,049 | 3.8M USD | −78.6% reduced | Q1 2023 2 quarters |
| Tiptree Inc | < 0.1% | 253,752 | 3.8M USD | −4.5% reduced | Q4 2021 7 quarters |
| Propetro Hldg Corp | < 0.1% | 455,003 | 3.7M USD | −55.0% reduced | Q3 2022 4 quarters |
| Uniqure NV | < 0.1% | 313,000 | 3.6M USD | −72.6% reduced | Q2 2020 13 quarters |
| Expro Group Holdings NV | < 0.1% | 200,924 | 3.6M USD | −12.1% reduced | Q1 2023 2 quarters |
| Atlas Energy Solutions Inc | < 0.1% | 201,656 | 3.5M USD | −36.0% reduced | Q1 2023 2 quarters |
| Avanos Med Inc | < 0.1% | 134,800 | 3.4M USD | −44.2% reduced | Q4 2022 3 quarters |
| Brighthouse Finl Inc | < 0.1% | 72,568 | 3.4M USD | −34.4% reduced | Q2 2022 5 quarters |
| CELH Celsius Holdings | < 0.1% | 21,894 | 3.3M USD | −89.9% reduced | Q4 2022 3 quarters |
| Ishares TR | < 0.1% | 16,400 | 3.1M USD | −89.8% reduced | Q2 2022 5 quarters |
| Axonics Inc | < 0.1% | 57,874 | 2.9M USD | −94.6% reduced | Q1 2023 2 quarters |
| Hayward HLDGS Inc | < 0.1% | 222,300 | 2.9M USD | −26.8% reduced | Q4 2022 3 quarters |
| Federal Rlty Invt TR New | < 0.1% | 29,400 | 2.8M USD | −38.2% reduced | Q1 2023 2 quarters |
| Boston Beer Inc | < 0.1% | 8,881 | 2.7M USD | −95.1% reduced | Q1 2023 2 quarters |
| DXCM Dexcom | < 0.1% | 20,918 | 2.7M USD | −98.7% reduced | Q2 2022 5 quarters |
| Sigma Lithium Corporation | < 0.1% | 61,979 | 2.5M USD | −86.6% reduced | Q1 2023 2 quarters |
| Altus Power Inc | < 0.1% | 461,600 | 2.5M USD | −46.7% reduced | Q2 2022 5 quarters |
| ASPN Aspen Aerogels | < 0.1% | 314,032 | 2.5M USD | −19.2% reduced | Q1 2022 6 quarters |
| ADM Archer Daniels Midland | < 0.1% | 32,488 | 2.5M USD | −82.2% reduced | Q2 2022 5 quarters |
| Installed Bldg Prods Inc | < 0.1% | 17,402 | 2.4M USD | −61.4% reduced | Q4 2022 3 quarters |
| Tegna Inc | < 0.1% | 150,000 | 2.4M USD | −8.3% reduced | Q1 2023 2 quarters |
| Luminar Technologies Inc | < 0.1% | 351,302 | 2.4M USD | −76.6% reduced | Q3 2022 4 quarters |
| Rogers Corp | < 0.1% | 14,800 | 2.4M USD | −63.1% reduced | Q1 2023 2 quarters |
| Goosehead Ins Inc | < 0.1% | 37,208 | 2.3M USD | −86.1% reduced | Q3 2022 4 quarters |
| Amerisafe Inc | < 0.1% | 41,300 | 2.2M USD | −21.0% reduced | Q4 2022 3 quarters |
| Lifestance Health Group Inc | < 0.1% | 234,400 | 2.1M USD | −76.6% reduced | Q1 2023 2 quarters |
| Armstrong World Inds Inc New | < 0.1% | 28,635 | 2.1M USD | −46.6% reduced | Q1 2023 2 quarters |
| Rayonier Inc | < 0.1% | 65,435 | 2.1M USD | −74.6% reduced | Q2 2022 5 quarters |
| Tpi Composites Inc | < 0.1% | 188,010 | 1.9M USD | −81.5% reduced | Q4 2021 7 quarters |
| The Lion Electric Company | < 0.1% | 1,050,100 | 1.9M USD | −0.3% reduced | Q4 2022 3 quarters |
| Merit Med Sys Inc | < 0.1% | 22,119 | 1.9M USD | −20.4% reduced | Q2 2021 9 quarters |
| Accolade Inc | < 0.1% | 136,181 | 1.8M USD | −84.6% reduced | Q3 2022 4 quarters |
| Pilgrims Pride Corp | < 0.1% | 80,800 | 1.7M USD | −70.7% reduced | Q1 2023 2 quarters |
| Builders Firstsource Inc | < 0.1% | 12,641 | 1.7M USD | −92.9% reduced | Q1 2023 2 quarters |
| Under Armour Inc | < 0.1% | 245,550 | 1.6M USD | −52.9% reduced | Q4 2022 3 quarters |
| Intra-Cellular Therapies Inc | < 0.1% | 25,121 | 1.6M USD | −89.3% reduced | Q3 2022 4 quarters |
| APO Apollo Global Management | < 0.1% | 20,550 | 1.6M USD | −97.2% reduced | Q1 2022 6 quarters |
| Alphatec HLDGS Inc | < 0.1% | 85,571 | 1.5M USD | −85.8% reduced | Q4 2020 11 quarters |
| SPDR Ser TR | < 0.1% | 37,600 | 1.5M USD | −63.9% reduced | Q1 2023 2 quarters |
| Guidewire Software Inc | < 0.1% | 19,800 | 1.5M USD | −60.2% reduced | Q1 2023 2 quarters |
| Hain Celestial Group Inc | < 0.1% | 110,417 | 1.4M USD | −13.7% reduced | Q1 2023 2 quarters |
| KDP Keurig Dr Pepper | < 0.1% | 41,660 | 1.3M USD | −95.4% reduced | Q4 2022 3 quarters |
| Crown HLDGS Inc | < 0.1% | 14,515 | 1.3M USD | −85.3% reduced | Q4 2022 3 quarters |
| Mbia Inc | < 0.1% | 145,400 | 1.3M USD | −41.5% reduced | Q4 2022 3 quarters |
| Select Sector SPDR TR | < 0.1% | 15,000 | 1.2M USD | −98.1% reduced | Q1 2019 18 quarters |
| Bridgebio Pharma Inc | < 0.1% | 66,674 | 1.1M USD | −32.8% reduced | Q1 2023 2 quarters |
| Guess Inc | < 0.1% | 56,000 | 1.1M USD | −8.0% reduced | Q4 2022 3 quarters |
| Sharecare Inc | < 0.1% | 598,300 | 1.0M USD | −54.0% reduced | Q3 2021 8 quarters |
| Borgwarner Inc | < 0.1% | 20,086 | 982.4K USD | −96.7% reduced | Q3 2022 4 quarters |
| Broadstone Net Lease Inc | < 0.1% | 62,700 | 968.1K USD | −80.1% reduced | Q1 2023 2 quarters |
| Aecom | < 0.1% | 11,300 | 957.0K USD | −96.8% reduced | Q3 2021 8 quarters |
| Silgan HLDGS Inc | < 0.1% | 20,200 | 947.2K USD | −88.4% reduced | Q1 2023 2 quarters |
| Stem Inc | < 0.1% | 162,580 | 930.0K USD | −57.1% reduced | Q4 2021 7 quarters |
| GOOGL Alphabet Inc. (Class A) | < 0.1% | 7,606 | 910.4K USD | −99.8% reduced | Q4 2022 3 quarters |
| Magnolia Oil & Gas Corp | < 0.1% | 35,100 | 733.6K USD | −86.4% reduced | Q1 2023 2 quarters |
| Omega Therapeutics Inc | < 0.1% | 129,389 | 724.6K USD | −1.4% reduced | Q3 2021 8 quarters |
| PNR Pentair | < 0.1% | 11,202 | 723.6K USD | −91.8% reduced | Q1 2023 2 quarters |
| Proterra Inc | < 0.1% | 599,662 | 719.6K USD | −52.9% reduced | Q2 2021 9 quarters |
| Li-Cycle Holdings Corp | < 0.1% | 127,137 | 705.6K USD | −39.8% reduced | Q1 2022 6 quarters |
| CRM Salesforce | < 0.1% | 3,187 | 673.3K USD | −99.8% reduced | Q4 2022 3 quarters |
| COP ConocoPhillips | < 0.1% | 6,487 | 672.2K USD | −43.0% reduced | Q1 2023 2 quarters |
| Milestone Pharmaceuticals In | < 0.1% | 232,659 | 663.1K USD | −81.8% reduced | Q4 2022 3 quarters |
| CMCSA Comcast | < 0.1% | 15,195 | 631.4K USD | −45.1% reduced | Q1 2023 2 quarters |
| Azure Pwr Global Ltd | < 0.1% | 342,334 | 605.9K USD | −2.7% reduced | Q3 2020 12 quarters |
| ADP Automatic Data Processing | < 0.1% | 2,366 | 520.0K USD | −54.5% reduced | Q1 2023 2 quarters |
| ARES Ares Management | < 0.1% | 5,330 | 513.5K USD | −97.7% reduced | Q4 2022 3 quarters |
| Kinsale Cap Group Inc | < 0.1% | 1,284 | 480.5K USD | −97.9% reduced | Q3 2021 8 quarters |
| Silence Therapeutics PLC | < 0.1% | 86,700 | 476.9K USD | −75.2% reduced | Q4 2021 7 quarters |
| Vincerx Pharma Inc | < 0.1% | 344,828 | 448.3K USD | −0.1% reduced | Q3 2021 8 quarters |
| Splunk Inc | < 0.1% | 4,030 | 427.5K USD | −98.0% reduced | Q1 2021 10 quarters |
| Sleep Number Corp | < 0.1% | 15,500 | 422.8K USD | −89.0% reduced | Q1 2023 2 quarters |
| Federated Hermes Inc | < 0.1% | 11,505 | 412.5K USD | −97.9% reduced | Q4 2022 3 quarters |
| Zhihu Inc | < 0.1% | 351,600 | 397.3K USD | −86.4% reduced | Q1 2023 2 quarters |
| Discover Finl Svcs | < 0.1% | 3,367 | 393.4K USD | −98.2% reduced | Q3 2022 4 quarters |
| Canoo Inc | < 0.1% | 805,082 | 386.0K USD | −29.8% reduced | Q4 2022 3 quarters |
| PAYX Paychex | < 0.1% | 3,435 | 384.3K USD | −25.4% reduced | Q1 2023 2 quarters |
| GOOG Alphabet Inc. (Class C) | < 0.1% | 3,079 | 372.5K USD | −99.5% reduced | Q3 2022 4 quarters |
| KLAC KLA Corporation | < 0.1% | 725 | 351.6K USD | −36.6% reduced | Q1 2023 2 quarters |
| CAT Caterpillar Inc. | < 0.1% | 1,336 | 328.7K USD | −68.2% reduced | Q1 2023 2 quarters |
| HUM Humana | < 0.1% | 713 | 318.8K USD | −99.6% reduced | Q1 2023 2 quarters |
| PSX Phillips 66 | < 0.1% | 3,109 | 296.5K USD | −94.0% reduced | Q1 2023 2 quarters |
| Taylor Morrison Home Corp | < 0.1% | 5,945 | 289.9K USD | −15.3% reduced | Q1 2023 2 quarters |
| UAL United Airlines Holdings | < 0.1% | 5,279 | 289.7K USD | −99.6% reduced | Q3 2022 4 quarters |
| Schrodinger Inc | < 0.1% | 5,790 | 289.0K USD | −95.6% reduced | Q4 2022 3 quarters |
| Bionomics Limited | < 0.1% | 126,000 | 277.2K USD | −1.6% reduced | Q4 2022 3 quarters |
| Cerus Corp | < 0.1% | 111,400 | 274.0K USD | −89.5% reduced | Q1 2023 2 quarters |
| Intercorp Finl Svcs Inc | < 0.1% | 10,903 | 270.8K USD | −14.2% reduced | Q1 2023 2 quarters |
| STLD Steel Dynamics | < 0.1% | 2,459 | 267.9K USD | −63.4% reduced | Q1 2023 2 quarters |
| Antero Resources Corp | < 0.1% | 11,465 | 264.0K USD | −98.3% reduced | Q3 2020 12 quarters |
| Mynaric AG | < 0.1% | 41,138 | 261.2K USD | −16.6% reduced | Q4 2021 7 quarters |
| PYPL PayPal | < 0.1% | 3,831 | 255.6K USD | −98.7% reduced | Q2 2022 5 quarters |
| LYB LyondellBasell | < 0.1% | 2,592 | 238.0K USD | −97.3% reduced | Q1 2023 2 quarters |
| E2OPEN Parent Holdings Inc | < 0.1% | 40,200 | 225.1K USD | −71.4% reduced | Q4 2022 3 quarters |
| Haleon PLC | < 0.1% | 25,100 | 210.3K USD | −93.7% reduced | Q4 2022 3 quarters |
| MTB M&T Bank | < 0.1% | 1,583 | 195.9K USD | −45.2% reduced | Q4 2022 3 quarters |
| MSCI MSCI | < 0.1% | 414 | 194.3K USD | −97.1% reduced | Q1 2023 2 quarters |
| Rackspace Technology Inc | < 0.1% | 67,239 | 182.9K USD | −68.6% reduced | Q1 2023 2 quarters |
| KEYS Keysight Technologies | < 0.1% | 1,073 | 179.7K USD | −99.1% reduced | Q1 2023 2 quarters |
| Futu HLDGS Ltd | < 0.1% | 4,505 | 179.0K USD | −94.5% reduced | Q1 2023 2 quarters |
| AOS A. O. Smith | < 0.1% | 2,419 | 176.1K USD | −98.5% reduced | Q4 2022 3 quarters |
| Enanta Pharmaceuticals Inc | < 0.1% | 8,200 | 175.5K USD | −31.5% reduced | Q1 2023 2 quarters |
| Amylyx Pharmaceuticals Inc | < 0.1% | 7,107 | 153.3K USD | −97.8% reduced | Q2 2022 5 quarters |
| Aeva Technologies Inc | < 0.1% | 119,300 | 149.1K USD | −14.8% reduced | Q3 2022 4 quarters |
| TRV Travelers Companies (The) | < 0.1% | 830 | 144.1K USD | −97.1% reduced | Q1 2023 2 quarters |
| Acm Resh Inc | < 0.1% | 10,100 | 132.1K USD | −92.3% reduced | Q1 2023 2 quarters |
| Chindata Group HLDGS Ltd | < 0.1% | 18,004 | 128.9K USD | −20.7% reduced | Q2 2022 5 quarters |
| Arcturus Therapeutics HLDGS | < 0.1% | 4,403 | 126.3K USD | −94.5% reduced | Q1 2022 6 quarters |
| NIO NIO | < 0.1% | 12,930 | 125.3K USD | −93.3% reduced | Q4 2022 3 quarters |
| MGM MGM Resorts | < 0.1% | 2,797 | 122.9K USD | −64.4% reduced | Q1 2023 2 quarters |
| DE Deere & Company | < 0.1% | 299 | 121.2K USD | −87.2% reduced | Q1 2023 2 quarters |
| Hutchmed China Ltd | < 0.1% | 9,735 | 116.8K USD | −63.9% reduced | Q4 2022 3 quarters |
| Cnx Res Corp | < 0.1% | 6,352 | 112.5K USD | −71.5% reduced | Q1 2023 2 quarters |
| Bigcommerce HLDGS Inc | < 0.1% | 11,000 | 109.5K USD | −99.2% reduced | Q4 2022 3 quarters |
| Cable One Inc | < 0.1% | 164 | 107.8K USD | −88.3% reduced | Q1 2023 2 quarters |
| Ringcentral Inc | < 0.1% | 3,290 | 107.7K USD | −99.6% reduced | Q2 2020 13 quarters |
| Biomerica Inc | < 0.1% | 75,000 | 102.0K USD | −67.4% reduced | Q4 2022 3 quarters |
| Bruker Corp | < 0.1% | 1,363 | 100.8K USD | −99.4% reduced | Q2 2022 5 quarters |
| Pennant Group Inc | < 0.1% | 8,025 | 98.5K USD | −63.8% reduced | Q1 2023 2 quarters |
| Assured Guaranty Ltd | < 0.1% | 1,706 | 95.2K USD | −63.1% reduced | Q1 2023 2 quarters |
| SYF Synchrony Financial | < 0.1% | 2,795 | 94.8K USD | −99.4% reduced | Q1 2023 2 quarters |
| Elastic N V | < 0.1% | 1,451 | 93.0K USD | −98.7% reduced | Q2 2020 13 quarters |
| Eagle Matls Inc | < 0.1% | 477 | 88.9K USD | −90.3% reduced | Q1 2023 2 quarters |
| Domo Inc | < 0.1% | 5,875 | 86.1K USD | −61.7% reduced | Q1 2023 2 quarters |
| EXPE Expedia Group | < 0.1% | 755 | 82.6K USD | −99.9% reduced | Q1 2022 6 quarters |
| Ryder Sys Inc | < 0.1% | 959 | 81.3K USD | −25.0% reduced | Q1 2023 2 quarters |
| Silicon Laboratories Inc | < 0.1% | 512 | 80.8K USD | −90.1% reduced | Q1 2023 2 quarters |
| Cleveland-Cliffs Inc New | < 0.1% | 4,752 | 79.7K USD | −97.6% reduced | Q3 2022 4 quarters |
| Helmerich & Payne Inc | < 0.1% | 2,118 | 75.1K USD | −48.7% reduced | Q1 2023 2 quarters |
| Brunswick Corp | < 0.1% | 847 | 73.4K USD | −99.8% reduced | Q1 2023 2 quarters |
| Maxlinear Inc | < 0.1% | 2,282 | 72.0K USD | −98.9% reduced | Q1 2023 2 quarters |
| Transmedics Group Inc | < 0.1% | 834 | 70.1K USD | −24.2% reduced | Q1 2023 2 quarters |
| Fathom Holdings Inc | < 0.1% | 9,450 | 67.5K USD | −0.8% reduced | Q4 2021 7 quarters |
| United States Stl Corp New | < 0.1% | 2,579 | 64.5K USD | −68.9% reduced | Q1 2023 2 quarters |
| Fidelity National Financial | < 0.1% | 1,772 | 63.8K USD | −98.9% reduced | Q4 2022 3 quarters |
| Corvel Corp | < 0.1% | 327 | 63.3K USD | −48.2% reduced | Q1 2023 2 quarters |
| Impinj Inc | < 0.1% | 700 | 62.8K USD | −99.3% reduced | Q1 2023 2 quarters |
| SYY Sysco | < 0.1% | 829 | 61.5K USD | −99.2% reduced | Q4 2022 3 quarters |
| Healthcare Svcs Group Inc | < 0.1% | 3,784 | 56.5K USD | −75.7% reduced | Q1 2023 2 quarters |
| Triton Intl Ltd | < 0.1% | 644 | 53.6K USD | −67.2% reduced | Q1 2023 2 quarters |
| ZTS Zoetis | < 0.1% | 311 | 53.5K USD | −98.9% reduced | Q1 2023 2 quarters |
| CTAS Cintas | < 0.1% | 107 | 53.2K USD | −99.0% reduced | Q1 2023 2 quarters |
| Renaissancere HLDGS Ltd | < 0.1% | 282 | 52.6K USD | −98.4% reduced | Q1 2023 2 quarters |
| Surmodics Inc | < 0.1% | 1,678 | 52.5K USD | −84.3% reduced | Q1 2023 2 quarters |
| TFC Truist Financial | < 0.1% | 1,629 | 49.4K USD | −99.4% reduced | Q4 2022 3 quarters |
| CNP CenterPoint Energy | < 0.1% | 1,682 | 49.0K USD | −99.9% reduced | Q1 2023 2 quarters |
| Joyy Inc | < 0.1% | 1,568 | 48.2K USD | −99.4% reduced | Q2 2022 5 quarters |
| Park Aerospace Corp | < 0.1% | 3,482 | 48.1K USD | −74.4% reduced | Q1 2023 2 quarters |
| TPR Tapestry, Inc. | < 0.1% | 1,081 | 46.3K USD | −69.4% reduced | Q1 2023 2 quarters |
| Cullen Frost Bankers Inc | < 0.1% | 428 | 46.0K USD | −99.7% reduced | Q4 2022 3 quarters |
| Ocugen Inc | < 0.1% | 83,872 | 45.6K USD | −47.3% reduced | Q1 2023 2 quarters |
| Tupperware Brands Corp | < 0.1% | 56,693 | 45.4K USD | −12.7% reduced | Q1 2023 2 quarters |
| Capri Holdings Limited | < 0.1% | 1,257 | 45.1K USD | −99.9% reduced | Q3 2020 12 quarters |
| Motorcar Pts Amer Inc | < 0.1% | 5,822 | 45.1K USD | −57.4% reduced | Q1 2023 2 quarters |
| Badger Meter Inc | < 0.1% | 304 | 44.9K USD | −83.4% reduced | Q1 2023 2 quarters |
| Plexus Corp | < 0.1% | 443 | 43.5K USD | −80.2% reduced | Q1 2023 2 quarters |
| Gossamer Bio Inc | < 0.1% | 34,917 | 41.9K USD | −34.9% reduced | Q1 2023 2 quarters |
| Franklin Str Pptys Corp | < 0.1% | 28,636 | 41.5K USD | −74.5% reduced | Q1 2023 2 quarters |
| Unisys Corp | < 0.1% | 10,272 | 40.9K USD | −86.8% reduced | Q1 2023 2 quarters |
| Appian Corp | < 0.1% | 853 | 40.6K USD | −39.7% reduced | Q1 2023 2 quarters |
| Granite Pt Mtg TR Inc | < 0.1% | 7,626 | 40.4K USD | −84.9% reduced | Q1 2023 2 quarters |
| Veritiv Corp | < 0.1% | 315 | 39.5K USD | −58.0% reduced | Q1 2023 2 quarters |
| Equity Comwlth | < 0.1% | 1,951 | 39.5K USD | −83.0% reduced | Q1 2023 2 quarters |
| Industrial Logistics Pptys T | < 0.1% | 11,924 | 39.4K USD | −87.3% reduced | Q1 2023 2 quarters |
| WTW Willis Towers Watson | < 0.1% | 166 | 39.1K USD | −91.3% reduced | Q1 2023 2 quarters |
| Eagle Pharmaceuticals Inc | < 0.1% | 1,998 | 38.8K USD | −61.8% reduced | Q1 2023 2 quarters |
| Universal Electrs Inc | < 0.1% | 3,998 | 38.5K USD | −68.7% reduced | Q1 2023 2 quarters |
| Corebridge Finl Inc | < 0.1% | 2,149 | 38.0K USD | −98.6% reduced | Q3 2022 4 quarters |
| Acuity Brands Inc | < 0.1% | 231 | 37.7K USD | −55.8% reduced | Q1 2023 2 quarters |
| Lincoln Natl Corp Ind | < 0.1% | 1,449 | 37.3K USD | −99.6% reduced | Q3 2021 8 quarters |
| Minerals Technologies Inc | < 0.1% | 647 | 37.3K USD | −23.9% reduced | Q1 2023 2 quarters |
| Belden Inc | < 0.1% | 388 | 37.1K USD | −33.7% reduced | Q1 2023 2 quarters |
| Microvast Holdings Inc | < 0.1% | 22,956 | 36.7K USD | −66.4% reduced | Q1 2023 2 quarters |
| Unifirst Corp Mass | < 0.1% | 235 | 36.4K USD | −68.4% reduced | Q1 2023 2 quarters |
| Openlane Inc | < 0.1% | 2,361 | 35.9K USD | −97.9% reduced | Q4 2022 3 quarters |
| Oxford Inds Inc | < 0.1% | 357 | 35.1K USD | −96.0% reduced | Q1 2023 2 quarters |
| IT Gartner | < 0.1% | 100 | 35.0K USD | −99.8% reduced | Q1 2023 2 quarters |
| Liveramp HLDGS Inc | < 0.1% | 1,218 | 34.8K USD | −81.2% reduced | Q1 2023 2 quarters |
| Gms Inc | < 0.1% | 497 | 34.4K USD | −96.5% reduced | Q1 2023 2 quarters |
| Allete Inc | < 0.1% | 590 | 34.2K USD | −98.3% reduced | Q2 2020 13 quarters |
| CVS CVS Health | < 0.1% | 493 | 34.1K USD | −97.0% reduced | Q4 2022 3 quarters |
| Hersha Hospitality TR | < 0.1% | 5,557 | 33.8K USD | −83.2% reduced | Q1 2023 2 quarters |
| Design Therapeutics Inc | < 0.1% | 5,349 | 33.7K USD | −47.2% reduced | Q1 2023 2 quarters |
| H World Group Ltd | < 0.1% | 848 | 32.9K USD | −99.9% reduced | Q1 2021 10 quarters |
| Bancorp Inc Del | < 0.1% | 998 | 32.6K USD | −71.4% reduced | Q1 2023 2 quarters |
| Donaldson Inc | < 0.1% | 520 | 32.5K USD | −97.4% reduced | Q1 2023 2 quarters |
| Aptargroup Inc | < 0.1% | 271 | 31.4K USD | −97.6% reduced | Q1 2023 2 quarters |
| Electronic Arts Inc | < 0.1% | 232 | 30.1K USD | −100.0% reduced | Q2 2021 9 quarters |
| DDOG Datadog | < 0.1% | 305 | 30.0K USD | −89.6% reduced | Q1 2023 2 quarters |
| Varonis Sys Inc | < 0.1% | 1,105 | 29.5K USD | −99.7% reduced | Q1 2023 2 quarters |
| Ww Intl Inc | < 0.1% | 4,322 | 29.0K USD | −91.1% reduced | Q1 2023 2 quarters |
| Owl Rock Capital Corporation | < 0.1% | 2,097 | 28.1K USD | −91.6% reduced | Q2 2022 5 quarters |
| Msc Indl Direct Inc | < 0.1% | 289 | 27.5K USD | −95.9% reduced | Q4 2021 7 quarters |
| Chesapeake Utils Corp | < 0.1% | 230 | 27.4K USD | −88.0% reduced | Q1 2023 2 quarters |
| Red Rock Resorts Inc | < 0.1% | 559 | 26.2K USD | −99.3% reduced | Q1 2023 2 quarters |
| Editas Medicine Inc | < 0.1% | 3,079 | 25.3K USD | −98.6% reduced | Q1 2023 2 quarters |
| Diodes Inc | < 0.1% | 270 | 25.0K USD | −86.7% reduced | Q1 2023 2 quarters |
| Now Inc | < 0.1% | 2,358 | 24.4K USD | −40.2% reduced | Q1 2023 2 quarters |
| Blackbaud Inc | < 0.1% | 337 | 24.0K USD | −95.3% reduced | Q1 2023 2 quarters |
| Dave & Busters Entmt Inc | < 0.1% | 533 | 23.8K USD | −99.5% reduced | Q3 2021 8 quarters |
| Telos Corp Md | < 0.1% | 9,194 | 23.5K USD | −68.5% reduced | Q1 2023 2 quarters |
| Hub Group Inc | < 0.1% | 285 | 22.9K USD | −99.2% reduced | Q4 2021 7 quarters |
| Wesbanco Inc | < 0.1% | 853 | 21.8K USD | −71.1% reduced | Q1 2023 2 quarters |
| Berkshire Hills Bancorp Inc | < 0.1% | 1,043 | 21.6K USD | −83.1% reduced | Q1 2023 2 quarters |
| Fluence Energy Inc | < 0.1% | 798 | 21.3K USD | −99.9% reduced | Q1 2023 2 quarters |
| Kirby Corp | < 0.1% | 271 | 20.9K USD | −22.1% reduced | Q4 2022 3 quarters |
| Yelp Inc | < 0.1% | 571 | 20.8K USD | −69.9% reduced | Q1 2023 2 quarters |
| Valvoline Inc | < 0.1% | 549 | 20.6K USD | −32.1% reduced | Q3 2021 8 quarters |
| Melco Resorts And Entmnt Ltd | < 0.1% | 1,674 | 20.4K USD | −99.4% reduced | Q2 2020 13 quarters |
| Cara Therapeutics Inc | < 0.1% | 7,212 | 20.4K USD | −50.6% reduced | Q1 2023 2 quarters |
| Allovir Inc | < 0.1% | 5,958 | 20.3K USD | −29.7% reduced | Q1 2023 2 quarters |
| Stifel Finl Corp | < 0.1% | 338 | 20.2K USD | −97.8% reduced | Q4 2022 3 quarters |
| Organogenesis HLDGS Inc | < 0.1% | 5,904 | 19.6K USD | −91.4% reduced | Q1 2023 2 quarters |
| Materion Corp | < 0.1% | 164 | 18.7K USD | −32.5% reduced | Q1 2023 2 quarters |
| Inotiv Inc | < 0.1% | 3,880 | 18.5K USD | −53.7% reduced | Q1 2023 2 quarters |
| Horace Mann Educators Corp N | < 0.1% | 618 | 18.3K USD | −93.1% reduced | Q1 2023 2 quarters |
| Techtarget Inc | < 0.1% | 584 | 18.2K USD | −37.1% reduced | Q1 2023 2 quarters |
| C4 Therapeutics Inc | < 0.1% | 6,557 | 18.0K USD | −72.4% reduced | Q1 2023 2 quarters |
| Woodward Inc | < 0.1% | 149 | 17.7K USD | −99.9% reduced | Q3 2021 8 quarters |
| Innospec Inc | < 0.1% | 174 | 17.5K USD | −90.3% reduced | Q1 2023 2 quarters |
| Api Group Corp | < 0.1% | 639 | 17.4K USD | −82.7% reduced | Q3 2021 8 quarters |
| Green Dot Corp | < 0.1% | 922 | 17.3K USD | −11.3% reduced | Q1 2023 2 quarters |
| Gevo Inc | < 0.1% | 11,118 | 16.9K USD | −82.4% reduced | Q1 2023 2 quarters |
| National Fuel Gas Co | < 0.1% | 328 | 16.8K USD | −94.5% reduced | Q4 2022 3 quarters |
| Pacira Biosciences Inc | < 0.1% | 420 | 16.8K USD | −99.9% reduced | Q1 2023 2 quarters |
| Brookfield Corp | < 0.1% | 500 | 16.8K USD | −99.9% reduced | Q4 2022 3 quarters |
| Independent Bank Group Inc | < 0.1% | 484 | 16.7K USD | −67.2% reduced | Q4 2022 3 quarters |
| Alarm Com HLDGS Inc | < 0.1% | 319 | 16.5K USD | −74.3% reduced | Q1 2023 2 quarters |
| Mannkind Corp | < 0.1% | 4,035 | 16.4K USD | −31.7% reduced | Q1 2023 2 quarters |
| Atai Life Sciences NV | < 0.1% | 9,444 | 16.2K USD | −80.4% reduced | Q4 2022 3 quarters |
| Aerovironment Inc | < 0.1% | 155 | 15.9K USD | −86.6% reduced | Q1 2023 2 quarters |
| Inovio Pharmaceuticals Inc | < 0.1% | 34,802 | 15.5K USD | −59.2% reduced | Q1 2023 2 quarters |
| Agilon Health Inc | < 0.1% | 881 | 15.3K USD | −41.3% reduced | Q1 2023 2 quarters |
| Cohu Inc | < 0.1% | 363 | 15.1K USD | −86.6% reduced | Q1 2023 2 quarters |
| Corcept Therapeutics Inc | < 0.1% | 665 | 14.8K USD | −73.9% reduced | Q1 2023 2 quarters |
| Vaxart Inc | < 0.1% | 19,654 | 14.3K USD | −80.9% reduced | Q1 2023 2 quarters |
| Gentherm Inc | < 0.1% | 250 | 14.1K USD | −74.1% reduced | Q1 2023 2 quarters |
| Sonic Automotive Inc | < 0.1% | 296 | 14.1K USD | −92.4% reduced | Q3 2022 4 quarters |
| Manpowergroup Inc Wis | < 0.1% | 173 | 13.7K USD | −46.4% reduced | Q1 2023 2 quarters |
| Qiagen NV | < 0.1% | 301 | 13.6K USD | −99.7% reduced | Q4 2022 3 quarters |
| Sangamo Therapeutics Inc | < 0.1% | 10,252 | 13.3K USD | −72.9% reduced | Q1 2023 2 quarters |
| Fuller H B Co | < 0.1% | 186 | 13.3K USD | −99.5% reduced | Q1 2023 2 quarters |
| Fb Finl Corp | < 0.1% | 471 | 13.2K USD | −60.4% reduced | Q4 2022 3 quarters |
| Invitae Corp | < 0.1% | 11,553 | 13.1K USD | −67.2% reduced | Q1 2023 2 quarters |
| Mesa Labs Inc | < 0.1% | 100 | 12.9K USD | −99.4% reduced | Q3 2022 4 quarters |
| Penn Entertainment Inc | < 0.1% | 513 | 12.3K USD | −76.2% reduced | Q1 2023 2 quarters |
| Standard Mtr Prods Inc | < 0.1% | 325 | 12.2K USD | −28.1% reduced | Q1 2023 2 quarters |
| Korn Ferry | < 0.1% | 235 | 11.6K USD | −93.8% reduced | Q1 2023 2 quarters |
| Ameris Bancorp | < 0.1% | 340 | 11.6K USD | −80.9% reduced | Q4 2022 3 quarters |
| Eagle Bancorp Inc Md | < 0.1% | 549 | 11.6K USD | −72.1% reduced | Q4 2022 3 quarters |
| Summit Hotel Pptys Inc | < 0.1% | 1,734 | 11.3K USD | −47.6% reduced | Q1 2023 2 quarters |
| 8X8 Inc New | < 0.1% | 2,666 | 11.3K USD | −99.5% reduced | Q1 2023 2 quarters |
| Chatham Lodging TR | < 0.1% | 1,187 | 11.1K USD | −60.9% reduced | Q1 2023 2 quarters |
| Ryanair Holdings PLC | < 0.1% | 100 | 11.1K USD | −99.8% reduced | Q4 2022 3 quarters |
| Ll Flooring Holdings Inc | < 0.1% | 2,861 | 11.0K USD | −82.4% reduced | Q1 2023 2 quarters |
| Spartannash Co | < 0.1% | 472 | 10.6K USD | −66.5% reduced | Q1 2023 2 quarters |
| American Assets TR Inc | < 0.1% | 549 | 10.5K USD | −80.4% reduced | Q4 2022 3 quarters |
| Championx Corporation | < 0.1% | 331 | 10.3K USD | −99.8% reduced | Q3 2022 4 quarters |
| Zimvie Inc | < 0.1% | 858 | 9.6K USD | −98.5% reduced | Q1 2023 2 quarters |
| Marten Trans Ltd | < 0.1% | 445 | 9.6K USD | −87.8% reduced | Q1 2023 2 quarters |
| Interface Inc | < 0.1% | 1,088 | 9.6K USD | −63.2% reduced | Q1 2023 2 quarters |
| Toll Brothers Inc | < 0.1% | 108 | 8.5K USD | −94.7% reduced | Q4 2022 3 quarters |
| American Pub Ed Inc | < 0.1% | 1,733 | 8.2K USD | −43.9% reduced | Q1 2023 2 quarters |
| Park Hotels & Resorts Inc | < 0.1% | 617 | 7.9K USD | −76.5% reduced | Q4 2022 3 quarters |
| Veeco Instrs Inc Del | < 0.1% | 274 | 7.0K USD | −75.3% reduced | Q1 2023 2 quarters |
| Blackline Inc | < 0.1% | 100 | 5.4K USD | −99.6% reduced | Q3 2022 4 quarters |
| Veru Inc | < 0.1% | 4,076 | 4.9K USD | −74.2% reduced | Q4 2022 3 quarters |
| Pagerduty Inc | < 0.1% | 200 | 4.5K USD | −84.1% reduced | Q1 2023 2 quarters |
| Alignment Healthcare Inc | < 0.1% | 688 | 4.0K USD | −64.9% reduced | Q4 2022 3 quarters |
| Resources Connection Inc | < 0.1% | 103 | 1.6K USD | −86.1% reduced | Q1 2023 2 quarters |
| NU Nu Holdings (Class A) | < 0.1% | 195 | 1.5K USD | −100.0% reduced | Q1 2023 2 quarters |
| CCI Crown Castle | < 0.1% | 12 | 1.4K USD | −100.0% reduced | Q4 2022 3 quarters |
| Myr Group Inc Del | < 0.1% | 10 | 1.4K USD | −98.3% reduced | Q1 2023 2 quarters |
| Kezar Life Sciences Inc | < 0.1% | 563 | 1.4K USD | −98.5% reduced | Q1 2023 2 quarters |
| Northwest Nat Hldg Co | < 0.1% | 29 | 1.2K USD | −99.4% reduced | Q1 2023 2 quarters |
| Viewray Inc | < 0.1% | 2,873 | 1.0K USD | −80.2% reduced | Q1 2023 2 quarters |
| Millerknoll Inc | < 0.1% | 62 | 911.0 USD | −97.3% reduced | Q1 2023 2 quarters |
| American Vanguard Corp | < 0.1% | 48 | 858.0 USD | −98.6% reduced | Q1 2023 2 quarters |
| Gopro Inc | < 0.1% | 198 | 818.0 USD | −99.9% reduced | Q1 2023 2 quarters |
| Suncoke Energy Inc | < 0.1% | 102 | 803.0 USD | −98.1% reduced | Q1 2023 2 quarters |
| Shutterstock Inc | < 0.1% | 16 | 779.0 USD | −97.8% reduced | Q1 2023 2 quarters |
| Latham Group Inc | < 0.1% | 202 | 750.0 USD | −98.7% reduced | Q1 2023 2 quarters |
| Enact HLDGS Inc | < 0.1% | 30 | 742.0 USD | −99.9% reduced | Q1 2022 6 quarters |
| Meta Materials Inc | < 0.1% | 3,430 | 738.0 USD | −98.5% reduced | Q1 2023 2 quarters |
| Healthstream Inc | < 0.1% | 30 | 737.0 USD | −94.5% reduced | Q1 2023 2 quarters |
| Geo Group Inc New | < 0.1% | 76 | 546.0 USD | −98.5% reduced | Q1 2023 2 quarters |
| Outset Med Inc | < 0.1% | 18 | 387.0 USD | −99.6% reduced | Q1 2023 2 quarters |
| Albany Intl Corp | < 0.1% | 4 | 373.0 USD | −99.7% reduced | Q1 2023 2 quarters |
| Arlo Technologies Inc | < 0.1% | 34 | 372.0 USD | −96.9% reduced | Q1 2023 2 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Shown: the 500 largest of 531 positions.
Plus 534 option positions, value of the underlying shares as reported 4.7B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 1.1B USD
- SPDR S&P 500 ETF TR Call 276.3M USD
- Invesco QQQ TR Put 257.2M USD
- UnitedHealth Group Put 211.3M USD
- FedEx Call 158.4M USD
- ResMed Call 116.9M USD
- SPDR Ser TR Put 104.4M USD
- Ishares TR Put 59.5M USD
- Enovix Corporation Call 52.6M USD
- Palantir Technologies Put 50.0M USD
Plus 40 positions in convertible bonds and bonds worth 366.1M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Ascendis Pharma A/S principal 29.0M USD 26.4M USD
- Pegasystems Inc principal 26.2M USD 23.7M USD
- Dish Network Corporation principal 23.9M USD 21.4M USD
- Sarepta Therapeutics Inc principal 9.0M USD 15.3M USD
- Liveperson Inc principal 16.0M USD 15.2M USD
- Liberty Latin America Ltd principal 15.9M USD 15.1M USD
- Fastly Inc principal 18.0M USD 15.0M USD
- Unity Software Inc principal 18.0M USD 14.4M USD
- Lyft Inc principal 15.3M USD 13.8M USD
- Guardant Health Inc principal 16.5M USD 11.8M USD
Breakdown by sector
- Technology 12.7%
- Health Care 8.4%
- Consumer Discretionary 6.7%
- Industrials 5.7%
- Financials 4.7%
- Utilities 3.9%
- Communication Services 3.9%
- Consumer Staples 3.1%
- Energy 2.5%
- Materials 1.4%
- Real Estate 1.3%
- not in our coverage 45.9%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors